Minerva Neurosciences Names Devin Smith Senior Vice President, General Counsel
25 juil. 2018 08h00 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...